HA
ARNA

Havens Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Havens Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24,500
Closed -$2.28M – 53
2021
Q4 		$2.28M Buy
+24,500
New +$1.61M 2.69% 14

Havens Advisors's ARNA Position: Q1 2022 in Review

Havens Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 24,500 shares — an estimated $2.28M sold.

Havens Advisors first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $2.28M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Havens Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Havens Advisors sold 24,500 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.28M.
  • Havens Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • Havens Advisors's Arena Pharmaceuticals Inc position peaked at $2.28M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Havens Advisors's 13F filing for Q1 2022, filed 13 Apr 2022.